Catalyst
Slingshot members are tracking this event:
Vertex plans to submit a New Drug Application (NDA) to the FDA for VX-661 in combination with ivacaftor in the second half of 2017
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| VRTX | Community voting in process | |||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Aug 24, 2017
Occurred Source:
http://investors.vrtx.com/releasedetail.cfm?ReleaseID=1038173
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Nda, Vx-661, Ivacaftor
